Penumbra (FRA:0P8) Cyclically Adjusted FCF per Share: €0.67 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:0P8 Penumbra Inc FRA:0P8
90 GF Score
Price €278.20
GF Value €288.22
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Penumbra Cyclically Adjusted FCF per Share?

Penumbra FRA:0P8 -0.22% 90 Cyclically Adjusted FCF per Share is €0.67 as of Mar. 2026. GuruFocus rates FRA:0P8 with a GF Score™ of 90/100 and a GF Value™ of €288.22 (Fairly Valued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Penumbra's adjusted free cash flow per share for the three months ended in Mar. 2026 was €1.603. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €0.67 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Penumbra's average Cyclically Adjusted FCF Growth Rate was 1200.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-19), Penumbra's current stock price is €278.20. Penumbra's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €0.67. Penumbra's Cyclically Adjusted Price-to-FCF of today is 415.22.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Penumbra was 4996.33. The lowest was 405.94. And the median was 752.40.


Penumbra  (FRA:0P8) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Penumbra's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=278.20/0.67
=415.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Penumbra was 4996.33. The lowest was 405.94. And the median was 752.40.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Penumbra Cyclically Adjusted FCF per Share Related Terms


Penumbra Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Penumbra's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Penumbra Cyclically Adjusted FCF per Share Chart

Penumbra Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.05 0.49

Penumbra Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.14 0.30 0.49 0.67

FRA:0P8 vs GMED, PODD, BRKR: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Penumbra's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Penumbra Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Penumbra's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Penumbra's Cyclically Adjusted Price-to-FCF falls into.


FRA:0P8
90GF Score
Penumbra Inc FRA:0P8
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Penumbra Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Penumbra's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.603/330.2130*330.2130
=1.603

Current CPI (Mar. 2026) = 330.2130.

Penumbra Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.232 241.018 -0.318
201609 0.062 241.428 0.085
201612 -0.474 241.432 -0.648
201703 -0.030 243.801 -0.041
201706 -0.041 244.955 -0.055
201709 0.160 246.819 0.214
201712 -0.130 246.524 -0.174
201803 0.178 249.554 0.236
201806 -0.051 251.989 -0.067
201809 0.225 252.439 0.294
201812 0.094 251.233 0.124
201903 -0.111 254.202 -0.144
201906 -0.045 256.143 -0.058
201909 0.354 256.759 0.455
201912 -0.080 256.974 -0.103
202003 -0.399 258.115 -0.510
202006 -0.713 257.797 -0.913
202009 -0.181 260.280 -0.230
202012 -0.132 260.474 -0.167
202103 -0.411 264.877 -0.512
202106 -0.146 271.696 -0.177
202109 0.693 274.310 0.834
202112 -0.397 278.802 -0.470
202203 -0.222 287.504 -0.255
202206 -1.102 296.311 -1.228
202209 -0.513 296.808 -0.571
202212 -0.055 296.797 -0.061
202303 0.221 301.836 0.242
202306 0.300 305.109 0.325
202309 0.657 307.789 0.705
202312 0.761 306.746 0.819
202403 0.758 312.332 0.801
202406 0.433 314.175 0.455
202409 1.173 315.301 1.228
202412 1.067 315.605 1.116
202503 0.839 319.799 0.866
202506 0.649 322.561 0.664
202509 0.911 324.800 0.926
202512 1.474 324.054 1.502
202603 1.603 330.213 1.603

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €0.67 mean?
Penumbra (FRA:0P8) has a Cyclically Adjusted FCF per Share of €0.67 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Penumbra and its competitors.
Is Penumbra's Cyclically Adjusted FCF per Share too high?
Penumbra's current Cyclically Adjusted FCF per Share is €0.67. Overall, Penumbra has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Penumbra's Cyclically Adjusted FCF per Share compare to GMED and PODD?
Penumbra's Cyclically Adjusted FCF per Share of €0.67 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Penumbra and its competitors. Penumbra's current Cyclically Adjusted FCF per Share is €0.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Penumbra stock overvalued right now?
Based on GuruFocus' analysis, Penumbra (FRA:0P8) is currently considered Fairly Valued. The stock's GF Value™ is €288.22, compared to a current price of €278.20 — trading 3.5% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €0.67. Penumbra's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Penumbra (FRA:0P8), the current Cyclically Adjusted FCF per Share is €0.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Penumbra (FRA:0P8) Overvalued in 2026?

Based on GuruFocus' analysis, Penumbra stock appears to be undervalued. The current stock price of €278.20 is trading 3.5% below its estimated GF Value™ of €288.22. GuruFocus considers Penumbra to be Fairly Valued.

Key valuation signals for FRA:0P8:

  • Cyclically Adjusted FCF per Share: €0.67
  • GF Value™: €288.22 vs. price of €278.20 (3.5% below fair value)
  • GF Score™: 90/100 with 1 warning sign

No single metric tells the full story. See the FRA:0P8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Penumbra Business Description

Other Exchanges PEN:USA
Address 1310 Harbor Bay Parkway, One Penumbra Place, Alameda, CA, USA, 94502
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
90GF Score

Get the complete analysis for FRA:0P8

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€278.20
Price
€288.22
GF Value